Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Apr
6
2024
EPA Proposes to Require Submission of Health and Safety Studies for 16 Chemicals Being Considered for TSCA Risk Evaluation Bergeson & Campbell, P.C.
Apr
5
2024
Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act Greenberg Traurig, LLP
Apr
5
2024
New York Cannabis Regulations Are (Initially Ruled) Unconstitutional, Says New York Judge ArentFox Schiff LLP
Apr
4
2024
Proposal to Revamp Alabama Medical Cannabis Program Met with Near-Unanimous Opposition Bradley Arant Boult Cummings LLP
Apr
4
2024
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective Foley & Lardner LLP
Apr
4
2024
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements Greenberg Traurig, LLP
Apr
4
2024
Take the Beer Goggles Off: Ambiguity Prevents Summary Judgment McDermott Will & Emery
Apr
4
2024
CTP Releases New 5-year Strategic Plan Keller and Heckman LLP
Apr
4
2024
AMS Requests Information to Update List of Bioengineered Foods Bergeson & Campbell, P.C.
Apr
3
2024
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
EPA Describes Future of Its Nanotechnology Research Bergeson & Campbell, P.C.
Apr
3
2024
FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO Mintz
Apr
3
2024
US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation Greenberg Traurig, LLP
Apr
3
2024
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
3
2024
FDA Revokes Standard of Identity for Frozen Cherry Pie Keller and Heckman LLP
Apr
3
2024
This Week in 340B: March 19 – 25, 2024 McDermott Will & Emery
Apr
3
2024
This Week in 340B: March 13 – 18, 2024 McDermott Will & Emery
Apr
3
2024
New Florida Third-Party Food Delivery Law in Effect Greenberg Traurig, LLP
Apr
3
2024
This Week in 340B: March 26 – April 1, 2024 McDermott Will & Emery
Apr
2
2024
NIOSH Science Blog Item Highlights 20 Years of NTRC’s Field Studies Team Bergeson & Campbell, P.C.
Apr
2
2024
Litigation Minute: Class-Action Challenges to Natural and Clean Beauty Product Claims K&L Gates
Apr
2
2024
Unpacking Averages: Adverse Events for Device-Lead Combination Products Epstein Becker & Green, P.C.
Apr
2
2024
FSIS Updates Guidelines for Label Approval Keller and Heckman LLP
Apr
2
2024
Soaring High on Hoverbikes: Look Ma, No Ground! Nishith Desai Associates
Apr
1
2024
FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness Foley & Lardner LLP
Apr
1
2024
Weed at Work: Can Georgia Employers Still Drug Test? Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
1
2024
Recent Delaware Coverage Decisions on Relatedness Leaves D&O Claim Uncertainties Hunton Andrews Kurth
Apr
1
2024
So, You’ve Been Sued in a Labeling Class Action. Now What? McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins